Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Elanco Animal Health | ELAN | Nov 19, 2024 | 13.31 | -1.04 |
Elastic | ESTC | Nov 19, 2024 | 88.27 | +2.57 |
Elbit Systems | ESLT | Nov 19, 2024 | 249.61 | +6.15 |
Eldorado Gold | EGO | Nov 19, 2024 | 16.33 | +2.13 |
Electra Battery Materials | ELBM | Nov 19, 2024 | 0.51 | +2.93 |
Electro-Sensors | ELSE | Nov 19, 2024 | 4.10 | -4.95 |
electroCore | ECOR | Nov 19, 2024 | 10.09 | +4.56 |
Electromed | ELMD | Nov 19, 2024 | 27.92 | -0.57 |
Electronic Arts | EA | Nov 19, 2024 | 166.13 | +1.29 |
Electrovaya | ELVA | Nov 19, 2024 | 2.29 | -3.78 |
Eledon Pharmaceuticals | ELDN | Nov 19, 2024 | 3.88 | -0.51 |
Element Solutions | ESI | Nov 19, 2024 | 27.71 | -1.14 |
Elevai Labs | ELAB | Nov 19, 2024 | 0.02 | -6.99 |
Elevance Health | ELV | Nov 19, 2024 | 394.20 | -1.62 |
Elevation Oncology | ELEV | Nov 19, 2024 | 0.58 | +5.45 |
Eli Lilly | LLY | Nov 19, 2024 | 729.73 | +0.35 |
Elicio Therapeutics | ELTX | Nov 19, 2024 | 5.20 | -1.80 |
Eliem Therapeutics | ELYM | Nov 19, 2024 | 5.11 | 0.00 |
Ellington Financial | EFC | Nov 19, 2024 | 12.37 | +0.90 |
Ellington Financial | EFC-B | Nov 19, 2024 | 23.08 | +0.61 |
Ellington Financial A Pref | EFC-A | Nov 19, 2024 | 25.29 | +0.36 |
Ellington Financial D Pref | EFC-D | Nov 19, 2024 | 22.81 | 0.00 |
Ellington Financial E Pref | EFC-E | Nov 19, 2024 | 25.45 | +0.02 |
Ellington Financial Pref | EFC-C | Nov 19, 2024 | 25.25 | -0.86 |
Ellington Residential Mortgage REIT | EARN | Nov 19, 2024 | 6.65 | +1.22 |
Ellomay Capital | ELLO | Nov 19, 2024 | 14.72 | 0.00 |
Ellsworth Growth | ECF | Nov 19, 2024 | 9.61 | +0.52 |
Ellsworth Growth A | ECF-A | Nov 19, 2024 | 23.21 | -0.87 |
Elme Communities | ELME | Nov 19, 2024 | 15.82 | -0.82 |
Eltek | ELTK | Nov 19, 2024 | 11.65 | +3.65 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.